Amlodipine Besylate Tablet
Product Images NDC 29300-398

8 FDA label images from Unichem Pharmaceuticals (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 29300-398). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)

Structure (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 01)
Chemical structure of amlodipine besylate showing its molecular arrangement, including a chlorophenyl group, an aminoethyl side chain, and ester functional groups, along with the besylate (C6H6O3S) counterion.*
FDA Label Image

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)

Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
A line graph depicting event rates over time in months, comparing Amlodipine to placebo. The vertical axis shows event rate, and the horizontal axis shows time up to 24 months with numbers at risk beneath. The Amlodipine line is consistently below the placebo line. The graph includes statistical data with a p-value of 0.003, a hazard ratio of 0.691, and a 95% confidence interval from 0.54 to 0.88.*
FDA Label Image

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)

Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
A forest plot chart depicting hazard ratios and 95% confidence intervals for various patient subgroups, comparing Amlodipine to placebo. Subgroups include age, gender, baseline sitting systolic blood pressure, baseline vessel disease, vessel stenosis, and PCI-stent strata, each showing the relative favor towards Amlodipine or placebo.*
FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 04)

FDA Label Image

Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 05)

FDA Label Image

2.5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 06)

2.5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 06)
Amlodipine Besylate Tablets USP 2.5 mg oral tablet label with NDC 29300-396-19. The label shows 90 tablets per container, manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. It includes storage instructions, dosage note, and a barcode.*
FDA Label Image

5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 07)

5mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 07)
Amlodipine Besylate 5 mg tablets label from Unichem Pharmaceuticals (USA), Inc. The label includes the NDC 29300-397-19, tablet strength of 5 mg, quantity of 90 tablets, and directions to dispense with a patient information leaflet. It notes storage instructions and safety precautions, and lists Unichem Laboratories Ltd. in India as the manufacturer and Unichem Pharmaceuticals (USA), Inc. as the manufacturer for the US market.*
FDA Label Image

10mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 08)

10mg-90s (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 08)
Amlodipine Besylate 10 mg tablets label from Unichem Pharmaceuticals (USA), Inc. The label indicates 90 tablets in the container with dosage form as oral tablets. Storage instructions specify 20° to 25°C (68° to 77°F) in light-resistant containers. Manufactured by Unichem Laboratories Ltd., India, for Unichem Pharmaceuticals (USA), Inc. The NDC number is 29300-398-19.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.